The Largest Pharmaceutical Companies and Britain's Serious Fraud Office in the News

Oil-for-food: UK probe to cover more companies
A UK government probe into whether GlaxoSmithKline, AstraZeneca and Eli Lilly & Co bribed the Saddam Hussein administration in Iraq may expand to other...

British ask Lilly for data on Iraq sales
British fraud investigators are questioning Eli Lilly and Co. and at least two other drug makers about possible kickbacks they paid to trade...

UK pulls Glaxo into Iraq fraud probe
Serious Fraud Office has requested documents from GlaxoSmithKline as part of an investigation into kickbacks or bribes that may have...

Three UK drugs firms investigated over alleged Iraq bribes
THREE British pharmaceutical companies are under investigation by the Serious Fraud Office over alleged bribes paid to the former Iraqi...

Drug firms face grilling on 'Saddam bribes'
Executives from GlaxoSmithKline, AstraZeneca and Eli Lilly may be interviewed by Britain's Serious Fraud Office as part of its investigation into...

British Pharma Biggies Face Iraq Probe
Britain's largest pharmaceutical companies are facing questions about the controversial UN oil for food program in Iraq...

UK Probes Glaxo, AstraZeneca Over Iraqi Bribe Allegations
Drug makers GlaxoSmithKline PLC and AstraZeneca PLC have been asked to give documents to the United Kingdom's Serious Fraud...

UK drug firms told to hand over files in Iraq investigation
The Serious Fraud Office has ordered the British drug companies GlaxoSmithKline and AstraZeneca to hand over confidential emails and files relating to...

Lilly joins SFO 'bribes' list
American group Eli Lilly has become the third drug company to confirm a request from Britain's Serious Fraud Office to...

Probe into Iraqi drug contracts stepped up
GlaxoSmithKline and AstraZeneca, the pharmaceutical groups, have been ordered to release confidential documents to the Serious Fraud...

UK fraud regulator investigates 3 drug companies over bribes to Saddam
Britain's Serious Fraud Office has demanded documents from three major drug makers in connection with allegations that the companies paid bribes...

3rd British pharmaceutical company under suspicion of fraud
Eli Lilly has been asked to hand over documents as part of an investigation into alleged bribes paid to former Iraqi dictator Saddam Hussein...

Glaxo, AstraZeneca Get UK Document Request on Oil for Food
GlaxoSmithKline Plc, the world's second-largest drugmaker, and AstraZeneca Plc, the UK's No.2 pharmaceutical company...

Drug firms probed over Iraq cash
GlaxoSmithKline and AstraZeneca have been asked to hand over papers as part of a probe into bribes allegedly paid to Saddam Hussein's former Iraq regime...

UK fraud office demands drug firms' Iraq documents
GlaxoSmithKline Plc (GSK.L: Quote, Profile, Research) and AstraZeneca Plc (AZN.L: Quote, Profile, Research) said on Sunday Britain's...

UK fraud watchdog demands documents from GlaxoSmithKline and...
Britain's Serious Fraud Office has demanded documents from drug giants GlaxoSmithKline PLC and AstraZeneca PLC in connection with allegations...

Drug firms face Iraq bribes probe
Pharmaceutical companies GlaxoSmithKline and AstraZeneca have been asked to hand over documents to the Serious Fraud Office as part of its investigation...

SFO targets drug groups over UN scandal
Executives from GlaxoSmithKline (GSK), AstraZeneca and Eli Lilly could be interviewed by the Serious Fraud Office (SFO) as part of its investigation into...

Most Popular Now

Lilly will supply an additional 150,000 doses of b…

Eli Lilly and Company (NYSE: LLY) announced a modified purchase agreement with the U.S. government to supply an additional 150,000 doses of bebtelovimab for approximately...

Bayer to sell men's health product Nebido™ to Grün…

Bayer and Grünenthal have entered into a definitive agreement regarding the sale of Bayer's men's health product Nebido™ (testosterone undecanoate), for a purchase price ...

Pfizer and BioNTech complete submission to Europea…

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced they have completed a submission to the European Medicines Agency (EMA) for an Omicron-adapted biva...

The fourth COVID-19 vaccine reduces the risk of de…

A new study by Tel Aviv University and Ben Gurion University of the Negev, in collaboration with the Israeli Ministry of Health, has found that the fourth COVID-19 vaccin...

Vaccine protection against COVID-19 short-lived, b…

Since COVID-19 vaccines first became available to protect against infection and severe illness, there has been much uncertainty about how long the protection lasts, and w...

AstraZeneca to acquire TeneoTwo and its clinical-s…

AstraZeneca announced an agreement to acquire TeneoTwo, Inc. (TeneoTwo)i, including its Phase I clinical-stage CD19/CD3 T-cell engager, TNB-486, currently under evaluatio...

Demonstration of a potent, universal coronavirus m…

The SARS-CoV-2 that causes COVID-19 has killed 6.3 million people worldwide since 2019, painfully highlighting the vulnerability of humanity to novel coronaviruses. Re...

Research shows investigational drug fosters nerve …

Scientists from the University of Birmingham have shown that a brain-penetrating candidate drug currently in development as a cancer therapy can foster regeneration of da...

NIH launches clinical trial of mRNA Nipah virus va…

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has launched an early-stage clinical trial evaluating an inv...

Anti-inflammatory compound shows potential in trea…

An anti-inflammatory compound may have the potential to treat systemic inflammation and brain injury in patients with severe COVID-19 and significantly reduce their chanc...

Vaccine-induced immune response to omicron wanes s…

Although COVID-19 booster vaccinations in adults elicit high levels of neutralizing antibodies against the Omicron variant of SARS-CoV-2, antibody levels decrease substan...

SARS-CoV-2 hijacks nanotubes between neurons to in…

COVID-19 often leads to neurological symptoms, such as a loss of taste or smell, or cognitive impairments (including memory loss and concentration difficulties), both dur...